Lycia Therapeutics, Inc. LYCA
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 124.32M | 124.32M | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 3.40M | 3.40M | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 127.72M | 127.72M | |||
|
|
|||||
| Total Current Assets | 127.72M | 127.72M | |||
| Net Property, Plant & Equipment | 4.35M | 4.35M | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 921.00K | 921.00K | |||
| Total Assets | 156.76M | 156.76M | |||
|
|
|||||
| Total Accounts Payable | 1.41M | 1.41M | |||
| Total Accrued Expenses | 7.22M | 7.22M | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 1.46M | 1.46M | |||
| Total Finance Division Other Current Liabilities | 47.00K | 47.00K | |||
| Total Other Current Liabilities | 47.00K | 47.00K | |||
| Total Current Liabilities | 10.14M | 10.14M | |||
|
|
|||||
| Total Current Liabilities | 10.14M | 10.14M | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | 1.71M | 1.71M | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 11.85M | 11.85M | |||
|
|
|||||
| Common Stock & APIC | 4.71M | 4.71M | |||
| Retained Earnings | -136.76M | -136.76M | |||
| Treasury Stock & Other | -97.00K | -97.00K | |||
| Total Common Equity | -132.14M | -132.14M | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | 277.06M | 277.06M | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | 277.06M | 277.06M | |||
|
|
|||||
| Total Common Equity | -132.14M | -132.14M | |||
| Total Preferred Equity | 277.06M | 277.06M | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 144.92M | 144.92M | |||
|
|
|||||